TotalSeq™-B1007 anti-mouse CD85k (gp49 Receptor) Antibody, CD85k, H1.1,BioLegend,144911

Clone H1.1 recognizes both gp49A and gp49B. Additional reported applications (for the relevant formats) includein vitroactivation of gp49B to inhibit cytokine production. The LEAF™ or Ultra-LEAF™ purified antibody is recommended for functional assays (contact ourcustom solutions team).

Host

Armenian Hamster

Reactivity

Mouse

Application

PG - Quality tested

Platform ID

BAB913896965

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-B1007 anti-mouse CD85k (gp49 Receptor) Antibody, CD85k, H1.1
Cat. No.144911
HostArmenian Hamster
RRIDAB_2941428 (BioLegend Cat. No. 144911)
IsotypeArmenian Hamster IgG
ReactivityMouse
ApplicationPG - Quality tested
ClonalityMonoclonal
Clone NumberH1.1
Concentration0.5 mg/mL
TargetCD85k
Immunogengp49B-Fc fusion protein
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-B oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

gp49, also known as ILT3, gp49b1 or CD85k, is a 49 kD glycoprotein expressed on activated NK cells and myeloid cells. It structurally resembles killer inhibitory receptors (KIR). gp49B is a type I membrane protein belonging to the Ig superfamily and contains an immunoreceptor tyrosine-based inhibitory motif (ITIM), while gp49A is a truncated molecule without ITIM. Upon activation following interaction with integrin avb3, the cytoplasmic tail associates with SHP-1 and SHP-2, which results in downregulation of cell activation and cytokine production.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.